Zinc(II) Iminopyridine Complexes as Antibacterial Agents: A Structure-to-Activity Study

Area of Science:

• Coordination Chemistry
• Antimicrobial Agents
• Drug Delivery

Background:

• Antibiotic resistance is a critical global health challenge.
• Metallodrugs, particularly metal coordination complexes, are promising candidates for novel antibacterial therapies.
• Schiff base complexes offer versatile structures for developing new therapeutic agents.

Purpose of the Study:

• To design and synthesize a novel series of Schiff base zinc(II) complexes.
• To evaluate the antibacterial efficacy of these complexes against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria.
• To investigate the influence of metal ions and inorganic ligands on antibacterial activity and formulation properties.

Main Methods:

• Synthesis of Schiff base zinc(II) complexes utilizing iminopyridine as the organic ligand.
• Assessment of antibacterial activity against planktonic cultures of Staphylococcus aureus and Escherichia coli.
• Formulation of an emulsion with a lipophilic zinc(II) complex for topical delivery and evaluation of release kinetics.

Main Results:

• The synthesized zinc(II) complexes exhibited moderate biocide activity against both tested bacterial strains.
• The antibacterial effect was attributed to the complexation of zinc(II) with the Schiff base ligand, showing enhanced activity compared to copper(II) analogs.
• Inorganic ligands influenced complex solubility but not significantly the antibacterial effect; sustained release (24 h) was achieved in a topical emulsion formulation.

Conclusions:

• Schiff base zinc(II) complexes represent a viable class of metallodrugs with potential against bacterial infections.
• The study highlights the importance of the metal center in enhancing antibacterial potency.
• Further research into these iminopyridine zinc(II) complexes is warranted for developing new antibacterial strategies.